{
    "clinical_study": {
        "@rank": "114178", 
        "acronym": "MISTY", 
        "arm_group": [
            {
                "arm_group_label": "MediENT", 
                "arm_group_type": "Experimental", 
                "description": "Right or left sinus cavity where MediENT will be place after randomization."
            }, 
            {
                "arm_group_label": "MeroPack", 
                "arm_group_type": "Active Comparator", 
                "description": "Right or left sinus cavity where MeroPack will be placed after randomization of MediENT is assigned."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the safety and effectiveness of MediENT to MeroPack\n      after FESS."
        }, 
        "brief_title": "A Prospective, Randomized, Multi-Center Evaluation of MediENT\u00ae Middle Turbinate Implant Versus MeroPack\u00ae, a Bioresorbable Nasal Dressing / Sinus Stent After Endoscopic Sinus Surgery", 
        "completion_date": {
            "#text": "February 2013", 
            "@type": "Actual"
        }, 
        "condition": "Synechia", 
        "detailed_description": {
            "textblock": "MediENT is designed to minimize lateralization of the middle turbinate, which can cause\n      scarring and obstruction of key sinus openings after endoscopic sinus surgery."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Subject is between the ages of 18 and 65 years\n\n          2. Subject scheduled to undergo bilateral endoscopic sinus surgery\n\n          3. Subject signs IRB-approved informed consent form\n\n          4. Subject agrees to comply with all study-related procedures\n\n        Exclusion Criteria:\n\n          1. History of removal of one or both middle turbinates\n\n          2. Significant sinonasal polyps\n\n          3. Presence of marked septal asymmetry\n\n          4. Presence of significant concha bullosa, which requires surgical excision\n\n          5. Presence of non-viable tissue at the implantation site\n\n          6. Has an autoimmune disease, e.g., lupus, Graves' disease, myasthenia gravis, Wegener's\n             granulomatosis\n\n          7. Known or suspected allergy to device components\n\n          8. Participating in another clinical trial which could affect the healing of the middle\n             turbinate\n\n          9. Uncontrolled diabetes\n\n         10. Known or suspected use of illicit drugs\n\n         11. Known or suspected alcoholism\n\n         12. Other medical illness that could prevent follow-up or increase the risk of surgery\n\n         13. Pregnant or unwilling to take pregnancy prevention measures\n\n         14. Subject is currently using CPAP (Continuous Positive Airway Pressure) for sleep apnea"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 21, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01733667", 
            "org_study_id": "CSA2011-01"
        }, 
        "intervention": [
            {
                "arm_group_label": "MediENT", 
                "description": "MediENT will be assigned to either the right or left side and positioned between the turbinate and nasal wall of the side assigned.  MeroPack will be place in between the turbinate and nasal wall of the side not assigned to MediENT", 
                "intervention_name": "MediENT", 
                "intervention_type": "Device", 
                "other_name": [
                    "MediENT", 
                    "MeroPack"
                ]
            }, 
            {
                "arm_group_label": "MeroPack", 
                "description": "MediENT will be assigned to either the right or left side and positioned between the turbinate and nasal wall of the side assigned. MeroPack will be place in between the turbinate and nasal wall of the side not assigned to MediENT", 
                "intervention_name": "MeroPack", 
                "intervention_type": "Device"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "synechia", 
            "Fess", 
            "sinus surgery"
        ], 
        "lastchanged_date": "June 3, 2013", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Fresno", 
                        "country": "United States", 
                        "state": "California", 
                        "zip": "93720"
                    }, 
                    "name": "Central California ENT Medical Group"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colorado Springs", 
                        "country": "United States", 
                        "state": "Colorado", 
                        "zip": "80909"
                    }, 
                    "name": "Colorado ENT & Allergy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Louisville", 
                        "country": "United States", 
                        "state": "Kentucky", 
                        "zip": "40207"
                    }, 
                    "name": "Advanced ENT and Allergy"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "McKinney", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "75079"
                    }, 
                    "name": "ENT Associates of Texas"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "San Antonio", 
                        "country": "United States", 
                        "state": "Texas", 
                        "zip": "78229"
                    }, 
                    "name": "Ear, Nose & Throat Clinics of San Antonio"
                }
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective, Randomized, Multi-Center Evaluation of MediENT\u00ae Middle Turbinate Implant Versus MeroPack\u00ae, a Bioresorbable Nasal Dressing / Sinus Stent After Endoscopic Sinus Surgery", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Miller synechia score at 8 weeks (Number and degree of synechia present between middle turbinate and lateral nasal wall at 8 weeks judged by an independent evaluator)", 
            "measure": "Miller synechia score at 8 weeks", 
            "safety_issue": "No", 
            "time_frame": "8 weeks post endoscopic sinus surgery"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01733667"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Miller synechia score at 4 weeks (Number and degree of synechia present between middle turbinate and lateral nasal wall at 4 weeks judged by an independent evaluator)\nTotal mean Miller score at 8 weeks", 
            "measure": "Miller Score at 4 & 8 weeks", 
            "safety_issue": "No", 
            "time_frame": "4 & 8 weeks post endoscopic sinus surgery"
        }, 
        "source": "ENTrigue Surgical, Inc.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "ENTrigue Surgical, Inc.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "December 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}